Kraslova-Carey, I., D'Antiga, L., Cavers, M., Ma, Y., Bansal, S., Byrne, J., et al. (2005). HBV DNA levels at week 9 and number of HBV core gene mutations predict outcome of lamivudine/interferon a treatment in infancy-acquired chronic hepatitis B. HEPATOLOGY, 42(4 S1), 582-582.

HBV DNA levels at week 9 and number of HBV core gene mutations predict outcome of lamivudine/interferon a treatment in infancy-acquired chronic hepatitis B

D'Antiga L;
2005

Abstract in rivista
Gastroenterology; Hepatology
English
2005
42
4 S1
582
582
none
Kraslova-Carey, I., D'Antiga, L., Cavers, M., Ma, Y., Bansal, S., Byrne, J., et al. (2005). HBV DNA levels at week 9 and number of HBV core gene mutations predict outcome of lamivudine/interferon a treatment in infancy-acquired chronic hepatitis B. HEPATOLOGY, 42(4 S1), 582-582.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/473242
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact